United Therapeutics Corporation Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
United Therapeutics Corporation (UTHR) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$6.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-05
- United Therapeutics Corporation other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$6.00M, a 600.00% decline year-over-year.
- United Therapeutics Corporation other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$11.10M, a 604.55% decline year-over-year.
- United Therapeutics Corporation other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $800.00K.
- United Therapeutics Corporation other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $100.00K, a 99.55% decline year-over-year.
- United Therapeutics Corporation other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $4.30M, a 54.26% decline from fiscal 2024.
- United Therapeutics Corporation other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $9.40M, a 77.99% decline from fiscal 2023.
- United Therapeutics Corporation other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $42.70M.
- United Therapeutics Corporation other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$32.50M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.00M 10-Q · filed 2026-08-05 | -$17.10M 10-Q · filed 2026-08-05 | -$16.30M derived: sum of 3 quarters · filed 2026-08-05 | -$16.20M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$11.10M 10-Q · filed 2026-05-06 | -$10.30M derived: sum of 2 quarters · filed 2026-05-06 | -$10.20M derived: sum of 3 quarters · filed 2026-05-06 | -$9.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $900.00K derived: sum of 2 quarters · filed 2026-02-25 | $2.10M derived: sum of 3 quarters · filed 2026-08-05 | $4.30M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $100.00K 10-Q · filed 2025-10-29 | $1.30M derived: sum of 2 quarters · filed 2026-08-05 | $3.50M 10-Q · filed 2025-10-29 | -$7.30M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $1.20M 10-Q · filed 2026-08-05 | $3.40M 10-Q · filed 2026-08-05 | -$7.40M derived: sum of 3 quarters · filed 2026-08-05 | $14.90M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $2.20M 10-Q · filed 2026-05-06 | -$8.60M derived: sum of 2 quarters · filed 2026-05-06 | $13.70M derived: sum of 3 quarters · filed 2026-05-06 | $14.40M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$10.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $11.50M derived: sum of 2 quarters · filed 2026-02-25 | $12.20M derived: sum of 3 quarters · filed 2026-02-25 | $9.40M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $22.30M 10-Q · filed 2025-10-29 | $23.00M derived: sum of 2 quarters · filed 2025-10-29 | $20.20M 10-Q · filed 2025-10-29 | $51.10M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $700.00K 10-Q · filed 2025-07-30 | -$2.10M 10-Q · filed 2025-07-30 | $28.80M derived: sum of 3 quarters · filed 2026-02-25 | $35.70M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | -$2.80M 10-Q · filed 2025-04-30 | $28.10M derived: sum of 2 quarters · filed 2026-02-25 | $35.00M derived: sum of 3 quarters · filed 2026-02-25 | $23.20M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $30.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $37.80M derived: sum of 2 quarters · filed 2026-02-25 | $26.00M derived: sum of 3 quarters · filed 2026-02-25 | $42.70M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | $6.90M 10-Q · filed 2024-10-30 | -$4.90M derived: sum of 2 quarters · filed 2024-10-30 | $11.80M 10-Q · filed 2024-10-30 | $40.40M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | -$11.80M 10-Q · filed 2024-07-31 | $4.90M 10-Q · filed 2024-07-31 | $33.50M derived: sum of 3 quarters · filed 2025-02-26 | $14.90M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | $16.70M 10-Q · filed 2024-05-01 | $45.30M derived: sum of 2 quarters · filed 2025-02-26 | $26.70M derived: sum of 3 quarters · filed 2025-02-26 | $15.50M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | $28.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $10.00M derived: sum of 2 quarters · filed 2025-02-26 | -$1.20M derived: sum of 3 quarters · filed 2025-02-26 | -$32.50M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | -$18.60M 10-Q · filed 2023-11-01 | -$29.80M derived: sum of 2 quarters · filed 2023-11-01 | -$61.10M 10-Q · filed 2023-11-01 | -$64.00M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | -$11.20M 10-Q · filed 2023-08-02 | -$42.50M 10-Q · filed 2023-08-02 | -$45.40M derived: sum of 3 quarters · filed 2024-02-21 | -$46.90M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | -$31.30M 10-Q · filed 2023-05-03 | -$34.20M derived: sum of 2 quarters · filed 2024-02-21 | -$35.70M derived: sum of 3 quarters · filed 2024-02-21 | -$37.50M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | -$2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$4.40M derived: sum of 2 quarters · filed 2024-02-21 | -$6.20M derived: sum of 3 quarters · filed 2024-02-21 | -$8.80M 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | -$1.50M 10-Q · filed 2022-11-02 | -$3.30M derived: sum of 2 quarters · filed 2022-11-02 | -$5.90M 10-Q · filed 2022-11-02 | -$15.60M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | -$1.80M 10-Q · filed 2022-08-03 | -$4.40M 10-Q · filed 2022-08-03 | -$14.10M derived: sum of 3 quarters · filed 2023-02-22 | -$16.50M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | -$2.60M 10-Q · filed 2022-05-04 | -$12.30M derived: sum of 2 quarters · filed 2023-02-22 | -$14.70M derived: sum of 3 quarters · filed 2023-02-22 | -$13.30M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | -$9.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$12.10M derived: sum of 2 quarters · filed 2023-02-22 | -$10.70M derived: sum of 3 quarters · filed 2023-02-22 | $0.00 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | -$2.40M 10-Q · filed 2021-11-03 | -$1.00M derived: sum of 2 quarters · filed 2021-11-03 | $9.70M 10-Q · filed 2021-11-03 | -$400.00K derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $1.40M 10-Q · filed 2021-08-04 | $12.10M 10-Q · filed 2021-08-04 | $2.00M derived: sum of 3 quarters · filed 2022-02-24 | $2.90M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $10.70M 10-Q · filed 2021-05-05 | $600.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.50M derived: sum of 3 quarters · filed 2022-02-24 | $1.70M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | -$10.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$9.20M derived: sum of 2 quarters · filed 2022-02-24 | -$9.00M derived: sum of 3 quarters · filed 2022-02-24 | -$6.30M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $900.00K 10-Q · filed 2020-10-28 | $1.10M derived: sum of 2 quarters · filed 2020-10-28 | $3.80M 10-Q · filed 2020-10-28 | $18.10M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | $200.00K 10-Q · filed 2020-07-29 | $2.90M 10-Q · filed 2020-07-29 | $17.20M derived: sum of 3 quarters · filed 2021-02-24 | $16.90M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | $2.70M 10-Q · filed 2020-04-29 | $17.00M derived: sum of 2 quarters · filed 2021-02-24 | $16.70M derived: sum of 3 quarters · filed 2021-02-24 | $16.50M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | $14.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $14.00M derived: sum of 2 quarters · filed 2021-02-24 | $13.80M derived: sum of 3 quarters · filed 2021-02-24 | $11.70M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | -$300.00K 10-Q · filed 2019-10-30 | -$500.00K derived: sum of 2 quarters · filed 2019-10-30 | -$2.60M 10-Q · filed 2019-10-30 | |||||
| 2018-06-30 | -$200.00K 10-Q · filed 2019-07-31 | -$2.30M 10-Q · filed 2019-07-31 | ||||||
| 2018-03-31 | -$2.10M 10-Q · filed 2019-05-01 | |||||||
| 2017-12-31 | -$2.80M 10-K · filed 2020-02-26 | |||||||
| 2017-09-30 | -$200.00K 10-Q · filed 2018-10-31 | -$100.00K derived: sum of 2 quarters · filed 2018-10-31 | $0.00 derived: sum of 3 quarters · filed 2018-10-31 | $0.00 derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $100.00K 10-Q · filed 2018-08-01 | $200.00K 10-Q · filed 2018-08-01 | $200.00K derived: sum of 3 quarters · filed 2019-02-27 | -$1.90M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $100.00K 10-Q · filed 2018-05-02 | $100.00K derived: sum of 2 quarters · filed 2019-02-27 | -$2.00M derived: sum of 3 quarters · filed 2019-02-27 | $3.10M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$2.10M derived: sum of 2 quarters · filed 2019-02-27 | $3.00M derived: sum of 3 quarters · filed 2019-02-27 | $3.60M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | -$2.10M 10-Q · filed 2017-10-25 | $3.00M derived: sum of 2 quarters · filed 2017-10-25 | $3.60M 10-Q · filed 2017-10-25 | $5.10M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-06-30 | $5.10M 10-Q · filed 2017-07-27 | $5.70M 10-Q · filed 2017-07-27 | $7.20M derived: sum of 3 quarters · filed 2018-02-21 | $5.20M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-03-31 | $600.00K 10-Q · filed 2017-04-26 | $2.10M derived: sum of 2 quarters · filed 2018-02-21 | $100.00K derived: sum of 3 quarters · filed 2018-02-21 | $1.80M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2015-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | -$500.00K derived: sum of 2 quarters · filed 2018-02-21 | $1.20M derived: sum of 3 quarters · filed 2018-02-21 | -$3.70M 10-K · filed 2018-02-21 | -$3.67M 10-K · filed 2016-02-25 | |||
| 2015-09-30 | -$2.00M 10-Q · filed 2016-10-27 | -$300.00K derived: sum of 2 quarters · filed 2016-10-27 | -$5.20M 10-Q · filed 2016-10-27 | -$5.20M 10-Q · filed 2015-10-27 | -$5.05M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2015-06-30 | $1.70M 10-Q · filed 2016-07-28 | $1.71M 10-Q · filed 2015-07-28 | -$3.20M 10-Q · filed 2016-07-28 | -$3.20M 10-Q · filed 2015-07-28 | -$3.05M derived: sum of 3 quarters · filed 2017-02-22 | -$5.36M derived: sum of 4 quarters · filed 2017-02-22 | ||
| 2015-03-31 | -$4.90M 10-Q · filed 2016-04-28 | -$4.91M 10-Q · filed 2015-04-28 | -$4.75M derived: sum of 2 quarters · filed 2017-02-22 | -$7.06M derived: sum of 3 quarters · filed 2017-02-22 | -$6.04M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2014-12-31 | $147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | -$2.16M derived: sum of 2 quarters · filed 2017-02-22 | -$1.14M derived: sum of 3 quarters · filed 2017-02-22 | -$3.60M 10-K · filed 2017-02-22 | -$3.55M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | -$2.30M 10-Q · filed 2015-10-27 | -$1.29M derived: sum of 2 quarters · filed 2015-10-27 | -$3.75M 10-Q · filed 2015-10-27 | -$1.87M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-30 | $1.01M 10-Q · filed 2015-07-28 | -$1.44M 10-Q · filed 2015-07-28 | $437.00K derived: sum of 3 quarters · filed 2016-02-25 | $2.49M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | -$2.46M 10-Q · filed 2015-04-28 | -$578.00K derived: sum of 2 quarters · filed 2016-02-25 | $1.47M derived: sum of 3 quarters · filed 2016-02-25 | $1.32M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $3.93M derived: sum of 2 quarters · filed 2016-02-25 | $3.78M derived: sum of 3 quarters · filed 2016-02-25 | $1.77M 10-K · filed 2016-02-25 | ||||
| 2013-09-30 | $2.05M 10-Q · filed 2014-10-28 | $1.90M derived: sum of 2 quarters · filed 2014-10-28 | -$106.00K 10-Q · filed 2014-10-28 | -$5.54M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | -$152.00K 10-Q · filed 2014-07-29 | -$2.16M 10-Q · filed 2014-07-29 | -$7.59M derived: sum of 3 quarters · filed 2015-02-24 | -$6.20M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | -$2.01M 10-Q · filed 2014-04-29 | -$7.44M derived: sum of 2 quarters · filed 2015-02-24 | -$6.05M derived: sum of 3 quarters · filed 2015-02-24 | -$7.42M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | -$5.43M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$4.04M derived: sum of 2 quarters · filed 2015-02-24 | -$5.42M derived: sum of 3 quarters · filed 2015-02-24 | -$4.07M 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $1.39M 10-Q · filed 2013-10-29 | $16.00K derived: sum of 2 quarters · filed 2013-10-29 | $1.36M 10-Q · filed 2013-10-29 | $1.12M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | -$1.37M 10-Q · filed 2013-07-25 | -$27.00K 10-Q · filed 2013-07-25 | -$271.00K derived: sum of 3 quarters · filed 2014-02-25 | -$2.39M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $1.34M 10-Q · filed 2013-04-25 | $1.10M derived: sum of 2 quarters · filed 2014-02-25 | -$1.02M derived: sum of 3 quarters · filed 2014-02-25 | -$2.21M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | -$244.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$2.36M derived: sum of 2 quarters · filed 2014-02-25 | -$3.55M derived: sum of 3 quarters · filed 2014-02-25 | -$1.71M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | -$2.12M 10-Q · filed 2012-11-01 | -$3.31M derived: sum of 2 quarters · filed 2012-11-01 | -$1.47M 10-Q · filed 2012-11-01 | |||||
| 2011-06-30 | -$1.19M 10-Q · filed 2012-07-26 | $651.00K 10-Q · filed 2012-07-26 | ||||||
| 2011-03-31 | $1.84M 10-Q · filed 2012-04-26 | |||||||
| 2010-12-31 | -$4.86M 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |